|
⚲
|
| Keyboard |
| SVLSF VI LLC | |
|---|---|
| Firm | SV Health Investors LLC |
| Address | One Boston Place, Suite 3900 Boston, MA 02108 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| SV Health Investors LLC | |||||
| SV Life Sciences Fund VI Strategic Partners LP | 021-284644 | Executive Officer | 13.1 M of 13.1 M |
13.3 M | |
| SV Life Sciences Fund VI Strategic Partners LP | 021-284644 | Executive Officer | 13.1 M of 13.1 M |
8.7 M | |
| SV Life Sciences Fund VI LP | 021-240550 | Executive Officer | 273.5 M of 400.0 M |
201.5 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2019-01-16 | Other | 778,663 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2019-01-16 | Other | 26,660 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 75,591 | ||
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 14,982 | ||
|
Tectonic Therapeutic Inc AVRO
Series B Preferred Stock · derivative
|
2018-06-25 | Conversion | 61,908 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 2,207,843 | ||
|
Tectonic Therapeutic Inc AVRO
Series A Preferred Stock · derivative
|
2018-06-25 | Conversion | 312,341 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Series A Preferred Stock · derivative
|
2018-06-25 | Conversion | 9,122,809 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Series B Preferred Stock · derivative
|
2018-06-25 | Conversion | 1,808,211 | $0.00 | |
|
Tectonic Therapeutic Inc AVRO
Common Stock
|
2018-06-25 | Conversion | 437,611 |